120 related articles for article (PubMed ID: 36931169)
1. Comparative transcriptome profile of mouse macrophages treated with the RhoA/Rock pathway inhibitors Y27632, Fingolimod (Gilenya), and Rezurock (Belumosudil, SLx-2119).
Subuddhi A; Uosef A; Zou D; Ubelaker HV; Ghobrial RM; Kloc M
Int Immunopharmacol; 2023 May; 118():110017. PubMed ID: 36931169
[TBL] [Abstract][Full Text] [Related]
2. Screening RhoA/ROCK inhibitors for the ability to prevent chronic rejection of mouse cardiac allografts.
Chen W; Chen S; Chen W; Li XC; Ghobrial RM; Kloc M
Transpl Immunol; 2018 Oct; 50():15-25. PubMed ID: 29885441
[TBL] [Abstract][Full Text] [Related]
3. Fingolimod (FTY720) prevents chronic rejection of rodent cardiac allografts through inhibition of the RhoA pathway.
Chen W; Chen W; Chen S; Uosef A; Ghobrial RM; Kloc M
Transpl Immunol; 2021 Apr; 65():101347. PubMed ID: 33131698
[TBL] [Abstract][Full Text] [Related]
4. Siponimod (Mayzent) Downregulates RhoA and Cell Surface Expression of the S1P1 and CX3CR1 Receptors in Mouse RAW 264.7 Macrophages.
Uosef A; Vaughn N; Chu X; Elshawwaf M; Abdelshafy AAA; Elsaid KMK; Ghobrial RM; Kloc M
Arch Immunol Ther Exp (Warsz); 2020 Jun; 68(3):19. PubMed ID: 32488676
[TBL] [Abstract][Full Text] [Related]
5. RhoA/Rho kinase signaling regulates transforming growth factor-β1-induced chondrogenesis and actin organization of synovium-derived mesenchymal stem cells through interaction with the Smad pathway.
Xu T; Wu M; Feng J; Lin X; Gu Z
Int J Mol Med; 2012 Nov; 30(5):1119-25. PubMed ID: 22922645
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of RhoA and mTORC2/Rictor by Fingolimod (FTY720) induces p21-activated kinase 1, PAK-1 and amplifies podosomes in mouse peritoneal macrophages.
Chen W; Ghobrial RM; Li XC; Kloc M
Immunobiology; 2018 Nov; 223(11):634-647. PubMed ID: 30005970
[TBL] [Abstract][Full Text] [Related]
7. ROCK inhibition impedes macrophage polarity and functions.
Liu Y; Tejpal N; You J; Li XC; Ghobrial RM; Kloc M
Cell Immunol; 2016 Feb; 300():54-62. PubMed ID: 26711331
[TBL] [Abstract][Full Text] [Related]
8. The RhoA/ROCK Pathway Ameliorates Adhesion and Inflammatory Infiltration Induced by AGEs in Glomerular Endothelial Cells.
Rao J; Ye Z; Tang H; Wang C; Peng H; Lai W; Li Y; Huang W; Lou T
Sci Rep; 2017 Jan; 7():39727. PubMed ID: 28054559
[TBL] [Abstract][Full Text] [Related]
9. RhoA/ROCK Pathway Activation is Regulated by AT1 Receptor and Participates in Smooth Muscle Migration and Dedifferentiation via Promoting Actin Cytoskeleton Polymerization.
Qi Y; Liang X; Dai F; Guan H; Sun J; Yao W
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751352
[TBL] [Abstract][Full Text] [Related]
10. Dasatinib inhibits actin fiber reorganization and promotes endothelial cell permeability through RhoA-ROCK pathway.
Dasgupta SK; Le A; Vijayan KV; Thiagarajan P
Cancer Med; 2017 Apr; 6(4):809-818. PubMed ID: 28316141
[TBL] [Abstract][Full Text] [Related]
11. Crystalline Silica Impairs Efferocytosis Abilities of Human and Mouse Macrophages: Implication for Silica-Associated Systemic Sclerosis.
Lescoat A; Ballerie A; Lelong M; Augagneur Y; Morzadec C; Jouneau S; Jégo P; Fardel O; Vernhet L; Lecureur V
Front Immunol; 2020; 11():219. PubMed ID: 32133004
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid receptor 1 but not 2 mediates macrophage phagocytosis by G(α)i/o /RhoA/ROCK signaling pathway.
Mai P; Tian L; Yang L; Wang L; Yang L; Li L
J Cell Physiol; 2015 Jul; 230(7):1640-50. PubMed ID: 25545473
[TBL] [Abstract][Full Text] [Related]
13. Rho-specific Guanine nucleotide exchange factors (Rho-GEFs) inhibition affects macrophage phenotype and disrupts Golgi complex.
Chen W; Zhao Y; Li XC; Kubiak JZ; Ghobrial RM; Kloc M
Int J Biochem Cell Biol; 2017 Dec; 93():12-24. PubMed ID: 29061365
[TBL] [Abstract][Full Text] [Related]
14. RhoA/ROCK-dependent pathway is required for TLR2-mediated IL-23 production in human synovial macrophages: suppression by cilostazol.
Park SY; Lee SW; Lee WS; Rhim BY; Lee SJ; Kwon SM; Hong KW; Kim CD
Biochem Pharmacol; 2013 Nov; 86(9):1320-7. PubMed ID: 23973526
[TBL] [Abstract][Full Text] [Related]
15. Targeted inhibition of renal Rho kinase reduces macrophage infiltration and lymphangiogenesis in acute renal allograft rejection.
Poosti F; Yazdani S; Dolman ME; Kok RJ; Chen C; Ding G; Lacombe M; Prakash J; van den Born J; Hillebrands JL; van Goor H; de Borst MH
Eur J Pharmacol; 2012 Nov; 694(1-3):111-9. PubMed ID: 22964464
[TBL] [Abstract][Full Text] [Related]
16. High glucose activates Raw264.7 macrophages through RhoA kinase-mediated signaling pathway.
Cheng CI; Chen PH; Lin YC; Kao YH
Cell Signal; 2015 Feb; 27(2):283-92. PubMed ID: 25446262
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of RhoA but not ROCK induces chondrogenesis of chick limb mesenchymal cells.
Kim MJ; Kim S; Kim Y; Jin EJ; Sonn JK
Biochem Biophys Res Commun; 2012 Feb; 418(3):500-5. PubMed ID: 22281493
[TBL] [Abstract][Full Text] [Related]
18. Dissonant response of M0/M2 and M1 bone-marrow-derived macrophages to RhoA pathway interference.
Liu Y; Chen W; Minze LJ; Kubiak JZ; Li XC; Ghobrial RM; Kloc M
Cell Tissue Res; 2016 Dec; 366(3):707-720. PubMed ID: 27628094
[TBL] [Abstract][Full Text] [Related]
19. α-TEA inhibits the growth and motility of human colon cancer cells via targeting RhoA/ROCK signaling.
Yao J; Gao P; Xu Y; Li Z
Mol Med Rep; 2016 Sep; 14(3):2534-40. PubMed ID: 27432222
[TBL] [Abstract][Full Text] [Related]
20. Membrane ERα attenuates myocardial fibrosis via RhoA/ROCK-mediated actin remodeling in ovariectomized female infarcted rats.
Lee TM; Lin SZ; Chang NC
J Mol Med (Berl); 2014 Jan; 92(1):43-51. PubMed ID: 24292258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
